Skip to Main Content

+

  • • Infection occurs after inhalation of sporangiospores, germination in a hyphal form

    • Pulmonary infection occurs in immunocompromised persons, follows a fulminant pattern

    • Distinct clinical syndromes:

    • -Rhinocerebral infection: Direct extension in CNS from paranasal sinus infection

      -Cutaneous infection: Burn patients

      -GI infection: Children with protein-calorie malnutrition

      -Disseminated infection: Uremic patients receiving deferoxamine therapy

++

Epidemiology

+

  • • Pulmonary fungal infections are rising due to widespread use of broad-spectrum antibiotics, immunosuppressive drugs, and HIV infection

    • Occur anywhere in world, some with characteristic endemic areas

    Rhizopus arrhizus (most common), absidia species, rhizomucor species

    • -Infection occurs in patients with diabetes, leukemia, immunosuppression

      -Common in decaying fruit, vegetables, soil, and manure

++

Symptoms and Signs

+

  • • Pulmonary infection: Fever, cough, pleuritic chest pain, hemoptysis

++

Imaging Findings

+

  • Chest film: 3 distinct patterns

    • 1. Limited disease with involvement of single lobe

      2. Diffuse or disseminated disease

      3. Endobronchial disease with obstruction and secondary bacterial infection

    Chest CT scan: Characteristic halo sign, ring enhancement, and air-crescent sign

+

  • • Demonstrating organism in symptomatic patients

    • No skin or serologic test

    • Fungi grow in culture as broad irregular nonseptate hyphae branch at 90-degree angles

    • Diagnosis most commonly made by histology

    • Sine qua non: Hyphal vascular invasion between internal elastic membrane and media of blood vessels causing thrombosis and infarction

+

  • • Chest x-ray

    • Chest CT scan

    • Sputum microscopy and culture

+

  • • Amphotericin B is standard treatment

    • Small group of patients have limited disease: Aggressive surgical resection + amphotericin B

    • Endobronchial form: Successful treatment with transbronchoscopic resection using laser therapy

++

Prognosis

+

  • • Mortality is 90% despite best treatment; death from fungal sepsis, pulmonary dysfunction, and hemoptysis

    • Those surgically treatable: Mortality 50%

    • Endobronchial treatment is generally successful

++

References

Piarrouz R et al: Assessment of preemptive treatment to prevent severe candidiasis in critically ill surgical patients. Crit Care Med 2004;32:2443.
Walsh TJ et al: Voriconazole compared with liposomal amphotericin B for empirical antifungal therapy in patients with neutropenia and persistent fever. NEJM 2002;346:225.  [PubMed: 11807146]

Want remote access to your institution's subscription?

Sign in to your MyAccess profile while you are actively authenticated on this site via your institution (you will be able to verify this by looking at the top right corner of the screen - if you see your institution's name, you are authenticated). Once logged in to your MyAccess profile, you will be able to access your institution's subscription for 90 days from any location. You must be logged in while authenticated at least once every 90 days to maintain this remote access.

Ok

About MyAccess

If your institution subscribes to this resource, and you don't have a MyAccess profile, please contact your library's reference desk for information on how to gain access to this resource from off-campus.

Subscription Options

AccessSurgery Full Site: One-Year Subscription

Connect to the full suite of AccessSurgery content and resources including more than 160 instructional videos, 16,000+ high-quality images, interactive board review, 20+ textbooks, and more.

$995 USD
Buy Now

Pay Per View: Timed Access to all of AccessSurgery

24 Hour Subscription $34.95

Buy Now

48 Hour Subscription $54.95

Buy Now

Pop-up div Successfully Displayed

This div only appears when the trigger link is hovered over. Otherwise it is hidden from view.